I am a pediatric ophthalmologist at Drottning Silvias Barn- och Ungdomssjukhus in Gothenburg, Sweden, specializing in retinopathy of prematurity (ROP) in both my clinical practice and research. Additionally, I serve as an associate professor at the Sahlgrenska Academy, University of Gothenburg, and am a member of Professor Ann Hellström's research group. Our research group focuses on the prediction, prevention, and treatment of ROP. We have developed online, web-based risk prediction algorithms, such as WINROP (Weight, Insulin-like Growth Factor 1, Neonatal, ROP) and DigiROP, to identify preterm infants who are at high risk of developing severe ROP. We have special interest prevention of ROP. In a randomized clinical trial, the Mega Donna Mega study, we report a 50% reduction of severe ROP in extremely preterm infants after postnatal enteral supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA).